Abstract
Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Current Neurovascular Research
Title:An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies
Volume: 11 Issue: 4
Author(s): Avijit Banik, Sudesh Prabhakar, Jasvinder Kalra and Akshay Anand
Affiliation:
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Abstract: Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Export Options
About this article
Cite this article as:
Banik Avijit, Prabhakar Sudesh, Kalra Jasvinder and Anand Akshay, An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies, Current Neurovascular Research 2014; 11 (4) . https://dx.doi.org/10.2174/1567202611666140902144836
DOI https://dx.doi.org/10.2174/1567202611666140902144836 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Osteoblastic Inflammatory Redox Model, using TNF-a, Glucose and Glucose- Oxidized Low- Density Lipoprotein: Targets for Minocycline
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Protocatechuic Acid Alkyl Esters: Hydrophobicity As a Determinant Factor for Inhibition of NADPH Oxidase
Current Medicinal Chemistry The Role of T-Type Calcium Channels in Epilepsy and Pain
Current Pharmaceutical Design Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Induced Cell-Based Transplantation to Therapeutically Target Spinal Cord Disorders)
Current Stem Cell Research & Therapy Patent Selections:
Recent Patents on Regenerative Medicine Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Calcium-related Neurotoxicity of Oxaliplatin: Understanding the Mechanisms to Drive Therapy
Current Medicinal Chemistry Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis
Current Pharmaceutical Design Clonidine: Clinical Pharmacology and Therapeutic Use in Pain Management
Current Clinical Pharmacology Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Imaging Characteristics of Spondyloarthropathy
Current Rheumatology Reviews Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
Current Neuropharmacology A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology Functional Genomics: New Insights into the Function of Low Levels of Gene Expression in Stem Cells
Current Genomics